vs

Side-by-side financial comparison of Solventum (SOLV) and Taylor Morrison Home Corp (TMHC). Click either name above to swap in a different company.

Solventum is the larger business by last-quarter revenue ($2.0B vs $1.4B, roughly 1.4× Taylor Morrison Home Corp). Taylor Morrison Home Corp runs the higher net margin — 7.1% vs 3.2%, a 4.0% gap on every dollar of revenue. On growth, Solventum posted the faster year-over-year revenue change (-3.7% vs -26.8%). Over the past eight quarters, Solventum's revenue compounded faster (-0.4% CAGR vs -16.5%).

Solventum Corporation is an American health care company that was spun off from 3M on April 1, 2024.

Taylor Morrison is one of the largest home building companies in the United States. Its corporate headquarters are in Scottsdale, Arizona. The company formed when Taylor Woodrow and Morrison Homes joined forces in July 2007. Taylor Morrison operates in Arizona, California, Colorado, Georgia, Florida, North Carolina, South Carolina, Nevada, Indiana, and Texas, building mid-to-upscale housing, as well as first-time and mid-market homes.

SOLV vs TMHC — Head-to-Head

Bigger by revenue
SOLV
SOLV
1.4× larger
SOLV
$2.0B
$1.4B
TMHC
Growing faster (revenue YoY)
SOLV
SOLV
+23.1% gap
SOLV
-3.7%
-26.8%
TMHC
Higher net margin
TMHC
TMHC
4.0% more per $
TMHC
7.1%
3.2%
SOLV
Faster 2-yr revenue CAGR
SOLV
SOLV
Annualised
SOLV
-0.4%
-16.5%
TMHC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
SOLV
SOLV
TMHC
TMHC
Revenue
$2.0B
$1.4B
Net Profit
$63.0M
$98.6M
Gross Margin
51.4%
21.0%
Operating Margin
6.3%
Net Margin
3.2%
7.1%
Revenue YoY
-3.7%
-26.8%
Net Profit YoY
103.2%
-53.8%
EPS (diluted)
$0.37
$1.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SOLV
SOLV
TMHC
TMHC
Q1 26
$1.4B
Q4 25
$2.0B
$2.1B
Q3 25
$2.1B
$2.1B
Q2 25
$2.2B
$2.0B
Q1 25
$2.1B
$1.9B
Q4 24
$2.1B
$2.4B
Q3 24
$2.1B
$2.1B
Q2 24
$2.1B
$2.0B
Net Profit
SOLV
SOLV
TMHC
TMHC
Q1 26
$98.6M
Q4 25
$63.0M
$174.0M
Q3 25
$1.3B
$201.4M
Q2 25
$90.0M
$193.6M
Q1 25
$137.0M
$213.5M
Q4 24
$31.0M
$242.5M
Q3 24
$122.0M
$251.1M
Q2 24
$89.0M
$199.5M
Gross Margin
SOLV
SOLV
TMHC
TMHC
Q1 26
21.0%
Q4 25
51.4%
22.0%
Q3 25
54.2%
22.7%
Q2 25
54.4%
23.0%
Q1 25
53.8%
24.4%
Q4 24
53.9%
23.9%
Q3 24
56.0%
25.0%
Q2 24
54.6%
23.7%
Operating Margin
SOLV
SOLV
TMHC
TMHC
Q1 26
Q4 25
6.3%
Q3 25
80.6%
Q2 25
9.9%
Q1 25
7.3%
Q4 24
6.6%
Q3 24
13.2%
Q2 24
11.7%
Net Margin
SOLV
SOLV
TMHC
TMHC
Q1 26
7.1%
Q4 25
3.2%
8.3%
Q3 25
60.4%
9.6%
Q2 25
4.2%
9.5%
Q1 25
6.6%
11.3%
Q4 24
1.5%
10.3%
Q3 24
5.9%
11.8%
Q2 24
4.3%
10.0%
EPS (diluted)
SOLV
SOLV
TMHC
TMHC
Q1 26
$1.12
Q4 25
$0.37
$1.77
Q3 25
$7.22
$2.01
Q2 25
$0.51
$1.92
Q1 25
$0.78
$2.07
Q4 24
$0.18
$2.29
Q3 24
$0.70
$2.37
Q2 24
$0.51
$1.86

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SOLV
SOLV
TMHC
TMHC
Cash + ST InvestmentsLiquidity on hand
$878.0M
$652.9M
Total DebtLower is stronger
$5.0B
Stockholders' EquityBook value
$5.0B
$6.2B
Total Assets
$14.3B
$9.8B
Debt / EquityLower = less leverage
1.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SOLV
SOLV
TMHC
TMHC
Q1 26
$652.9M
Q4 25
$878.0M
$850.0M
Q3 25
$1.6B
$370.6M
Q2 25
$492.0M
$130.2M
Q1 25
$534.0M
$377.8M
Q4 24
$762.0M
$487.2M
Q3 24
$772.0M
$256.4M
Q2 24
$897.0M
$246.8M
Total Debt
SOLV
SOLV
TMHC
TMHC
Q1 26
Q4 25
$5.0B
$2.3B
Q3 25
$5.1B
$2.2B
Q2 25
$7.8B
$2.1B
Q1 25
$7.9B
$2.1B
Q4 24
$8.0B
$2.1B
Q3 24
$8.1B
$2.1B
Q2 24
$8.3B
$2.2B
Stockholders' Equity
SOLV
SOLV
TMHC
TMHC
Q1 26
$6.2B
Q4 25
$5.0B
$6.3B
Q3 25
$5.0B
$6.2B
Q2 25
$3.6B
$6.1B
Q1 25
$3.3B
$6.0B
Q4 24
$3.0B
$5.9B
Q3 24
$3.2B
$5.7B
Q2 24
$2.9B
$5.5B
Total Assets
SOLV
SOLV
TMHC
TMHC
Q1 26
$9.8B
Q4 25
$14.3B
$9.8B
Q3 25
$14.0B
$9.6B
Q2 25
$15.1B
$9.5B
Q1 25
$14.5B
$9.4B
Q4 24
$14.5B
$9.3B
Q3 24
$14.7B
$9.3B
Q2 24
$14.6B
$9.1B
Debt / Equity
SOLV
SOLV
TMHC
TMHC
Q1 26
Q4 25
1.00×
0.36×
Q3 25
1.03×
0.35×
Q2 25
2.14×
0.35×
Q1 25
2.43×
0.35×
Q4 24
2.71×
0.36×
Q3 24
2.54×
0.37×
Q2 24
2.90×
0.39×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SOLV
SOLV
TMHC
TMHC
Operating Cash FlowLast quarter
$95.0M
Free Cash FlowOCF − Capex
$32.0M
FCF MarginFCF / Revenue
1.6%
Capex IntensityCapex / Revenue
3.2%
Cash ConversionOCF / Net Profit
1.51×
TTM Free Cash FlowTrailing 4 quarters
$-10.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SOLV
SOLV
TMHC
TMHC
Q1 26
Q4 25
$95.0M
$646.4M
Q3 25
$76.0M
$219.6M
Q2 25
$169.0M
$-126.0M
Q1 25
$29.0M
$77.2M
Q4 24
$219.0M
$438.2M
Q3 24
$169.0M
$135.9M
Q2 24
$355.0M
$-233.3M
Free Cash Flow
SOLV
SOLV
TMHC
TMHC
Q1 26
Q4 25
$32.0M
$635.3M
Q3 25
$-21.0M
$206.6M
Q2 25
$59.0M
$-133.6M
Q1 25
$-80.0M
$68.7M
Q4 24
$92.0M
$428.2M
Q3 24
$76.0M
$127.1M
Q2 24
$297.0M
$-241.7M
FCF Margin
SOLV
SOLV
TMHC
TMHC
Q1 26
Q4 25
1.6%
30.3%
Q3 25
-1.0%
9.9%
Q2 25
2.7%
-6.6%
Q1 25
-3.9%
3.6%
Q4 24
4.4%
18.2%
Q3 24
3.7%
6.0%
Q2 24
14.3%
-12.1%
Capex Intensity
SOLV
SOLV
TMHC
TMHC
Q1 26
Q4 25
3.2%
0.5%
Q3 25
4.6%
0.6%
Q2 25
5.1%
0.4%
Q1 25
5.3%
0.4%
Q4 24
6.1%
0.4%
Q3 24
4.5%
0.4%
Q2 24
2.8%
0.4%
Cash Conversion
SOLV
SOLV
TMHC
TMHC
Q1 26
Q4 25
1.51×
3.71×
Q3 25
0.06×
1.09×
Q2 25
1.88×
-0.65×
Q1 25
0.21×
0.36×
Q4 24
7.06×
1.81×
Q3 24
1.39×
0.54×
Q2 24
3.99×
-1.17×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SOLV
SOLV

Infection Prevention And Surgical Solutions$752.0M38%
Cost Of Software And Rentals$508.0M25%
Health Information Systems Segment$347.0M17%
Dental Solutions Segment$343.0M17%
Related Party$14.0M1%

TMHC
TMHC

Home closings revenue, net$1.3B95%
Financial services revenue, net$49.3M4%
Land closings revenue$14.5M1%
Amenity and other revenue$11.9M1%

Related Comparisons